Oasis of Hope, founded by the late Dr. Ernesto Contreras Sr. in 1963, continues to provide alternative cancer treatments that combine traditional and holistic therapies for a comprehensive approach. Through a multidisciplinary team of oncologists, nutritionists, and other treatment specialists, Oasis of Hope designs personalized strategies incorporating treatments such as angiogenesis inhibitors therapy.
Angiogenesis inhibitors therapy helps prevent cancer from spreading by targeting a process known as angiogenesis, which is the formation of new blood vessels in response to chemical signals from wounds and damaged tissue. While it promotes the healing of wounds and restores blood flow to injured tissue in a healthy body, angiogenesis also contributes to the growth and spread of cancer by enabling tumors to grow diseased blood vessels. Many cancers also produce vascular endothelial growth factor (VEGF), which promotes angiogenesis by boosting the survival of endothelial cells that form new blood vessels.
Potential therapies involving angiogenesis inhibitors include combined modality therapy (CMT), which interferes with VEGF production. In particular, CMT can suppress the production of VEGF or block endothelial cell receptors that allow responses to VEGF.